FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ferre Maurice R 		2. Issuer Name and Ticker or Trading Symbol

MAKO Surgical Corp. [ MAKO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President, CEO and Chairman
(Last)          (First)          (Middle)

C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/2/2011
(Street)

FT. LAUDERDALE, FL 33317
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   2/2/2011     F    10195   D $15.93   811593   D    
Common Stock   2/4/2011     F    2278   D $15.77   809315   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   $16.32   2/3/2011     A      150000         (1) 2/3/2021   Common Stock   150000   $0.00   150000   D    
Performance Shares   $0.00   2/3/2011     A      300000   (2)        (2)   (2) Common Stock   300000   $0.00   300000   D    

Explanation of Responses:
( 1)  Vests and becomes exercisable ratably quarterly over four years commencing on the grant date.
( 2)  Represents the maximum number of performance shares, if any, that could be earned at the end of the performance period (i.e., March 31, 2013 or the date of a change of control), based on the achievement of certain threshold, target, and stretch goals tied to the Company's stock price. The actual number of performance shares that can be earned ranges from 0 to 300,000 shares. Fifty percent (50%) of the earned performance shares will vest on March 31, 2013 with the remaining fifty percent (50%) to vest on March 31, 2014; provided, however, that in the event of a termination in connection with a change of control, one hundred percent (100%) of the earned performance shares will vest on the date of termination. Each performance share represents a contingent right to receive one share of the Company's common stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ferre Maurice R
C/O MAKO SURGICAL CORP.
2555 DAVIE ROAD
FT. LAUDERDALE, FL 33317 		X
President, CEO and Chairman

Signatures
/s/ Menashe R. Frank, attorney in fact 2/4/2011
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Mako Surgical Corp. (MM) Charts.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Mako Surgical Corp. (MM) Charts.